149 related articles for article (PubMed ID: 24283960)
1. Crystal polymorphs of barbital: news about a classic polymorphic system.
Zencirci N; Griesser UJ; Gelbrich T; Apperley DC; Harris RK
Mol Pharm; 2014 Jan; 11(1):338-50. PubMed ID: 24283960
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of tedisamil dihydrochloride.
Henck JO; Finner E; Burger A
J Pharm Sci; 2000 Sep; 89(9):1151-9. PubMed ID: 10944380
[TBL] [Abstract][Full Text] [Related]
3. Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications.
Braun DE; Gelbrich T; Kahlenberg V; Tessadri R; Wieser J; Griesser UJ
J Pharm Sci; 2009 Jun; 98(6):2010-26. PubMed ID: 19009597
[TBL] [Abstract][Full Text] [Related]
4. The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.
Sieger P; Werthmann U; Saouane S
Eur J Pharm Sci; 2023 Jul; 186():106447. PubMed ID: 37044200
[TBL] [Abstract][Full Text] [Related]
5. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical.
Braun DE; Vickers M; Griesser UJ
Mol Pharm; 2019 Jul; 16(7):3221-3236. PubMed ID: 31075201
[TBL] [Abstract][Full Text] [Related]
6. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A
J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561
[TBL] [Abstract][Full Text] [Related]
7. Studies on the polymorphism of barbital.
Grabowska I; Kaliszan R
Pol J Pharmacol Pharm; 1976; 28(5):529-36. PubMed ID: 1012979
[TBL] [Abstract][Full Text] [Related]
8. Conformational color polymorphism and control of crystallization of 5-methyl-2-[(4-methyl-2-nitrophenyl)amino]-3-thiophenecarbonitrile.
He X; Griesser UJ; Stowell JG; Borchardt TB; Byrn SR
J Pharm Sci; 2001 Mar; 90(3):371-88. PubMed ID: 11170030
[TBL] [Abstract][Full Text] [Related]
9. Understanding the polymorphic behavior of sibenadet hydrochloride through detailed studies integrating structural and dynamical assessment.
Cosgrove SD; Steele G; Austin TK; Plumb AP; Stensland B; Ferrari E; Roberts KJ
J Pharm Sci; 2005 Nov; 94(11):2403-15. PubMed ID: 16200581
[TBL] [Abstract][Full Text] [Related]
10. Phase transformation in conformational polymorphs of nimesulide.
Sanphui P; Sarma B; Nangia A
J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
Tong HH; Shekunov BY; York P; Chow AH
Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
[TBL] [Abstract][Full Text] [Related]
12. Polymorph screening of an active material.
Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
[TBL] [Abstract][Full Text] [Related]
13. Solid state characterizations and analysis of stability in azelnidipine polymorphs.
Li D; Wang M; Yang C; Wang J; Ren G
Chem Pharm Bull (Tokyo); 2012; 60(8):995-1002. PubMed ID: 22863703
[TBL] [Abstract][Full Text] [Related]
14. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
Liu J; Svärd M; Hippen P; Rasmuson ÅC
J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
[TBL] [Abstract][Full Text] [Related]
15. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
Niederwanger V; Gozzo F; Griesser UJ
J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
[TBL] [Abstract][Full Text] [Related]
16. Micronization and polymorphic conversion of tolbutamide and barbital by rapid expansion of supercritical solutions.
Shinozaki H; Oguchi T; Suzuki S; Aoki K; Sako T; Morishita S; Tozuka Y; Moribe K; Yamamoto K
Drug Dev Ind Pharm; 2006 Aug; 32(7):877-91. PubMed ID: 16908425
[TBL] [Abstract][Full Text] [Related]
17. (14) N nuclear quadrupole resonance study of piroxicam: confirmation of new polymorphic form V.
Lavrič Z; Pirnat J; Lužnik J; Puc U; Trontelj Z; Srčič S
J Pharm Sci; 2015 Jun; 104(6):1909-1918. PubMed ID: 25776345
[TBL] [Abstract][Full Text] [Related]
18. Characterization of piroxicam crystal modifications.
Vrecer F; Vrbinc M; Meden A
Int J Pharm; 2003 Apr; 256(1-2):3-15. PubMed ID: 12695006
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
Kimura K; Hirayama F; Uekama K
J Pharm Sci; 1999 Apr; 88(4):385-91. PubMed ID: 10187747
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical relationships of three solid state forms of stavudine.
Gandhi RB; Bogardus JB; Bugay DE; Perrone RK; Kaplan MA
Int J Pharm; 2000 May; 201(2):221-37. PubMed ID: 10878328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
